Clin2
NCT07157020Possibly a fitNot yet recruiting

Preventing and treating brain bleeds in premature infants

Intraventricular Hemorrhage of Prematurity

Part of Brain & nervous system, Genetic & congenital clinical trials.

This trial studies better ways to prevent, catch early, and treat brain bleeds in premature babies. It focuses on babies who already have a brain bleed that causes fluid buildup (hydrocephalus) but haven't received any drainage treatment yet.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Up to 4 weeks
Study type
Interventional

Who can take part

  • Your baby was born between 23 weeks and 36 weeks, 6 days of pregnancy.
  • Your baby has a confirmed brain bleed that led to hydrocephalus (extra fluid in the brain).
  • Your baby has not had any procedure to drain the extra fluid from around the brain yet.
  • The hydrocephalus is not caused by a birth defect, infection, or other condition unrelated to the brain bleed.
  • Your baby has not been treated for hydrocephalus or had a suspected brain infection before enrollment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07198360Not yet recruiting
Bleeding in the brain in very premature babies

This study looks at the outcomes of brain bleeding (intraventricular hemorrhage) in very premature babies. It aims to understand how these babies do and what helps them, which may lead to better care.

NCT05617833Recruiting· Phase 1
Test EPO and melatonin for brain bleeding in very preterm babies

This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.

St. Petersburg, Florida
NCT06797219Recruiting
Light therapy device study for newborns with severe brain bleeding

This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.

Newark, New Jersey
NCT07733778Not yet recruiting
Washing out severe brain bleeds in newborns

This trial tests a treatment called neuroendoscopic lavage—a way to wash out a severe brain bleed in newborns using a tiny camera. It may help prevent fluid buildup and brain damage. Doctors want to see if it works better than regular care for babies under one month old with this condition.

NCT07412886Not yet recruiting
Advanced MRI for brain bleeding in newborns

This study uses advanced MRI scans to look at the brains of newborns who have had bleeding in the brain (IVH) and developed a condition called PHVD (fluid buildup after bleeding). The goal is to learn more about the brain and how it is affected, which could help improve care for these babies.

Liverpool
NCT07662174Not yet recruiting· Phase 1/Phase 2
Preventing fluid buildup after severe brain bleed

This trial tests whether a special medication given directly into the brain's fluid spaces can prevent fluid buildup (hydrocephalus) after a severe brain bleed. If you've had a severe aneurysm bleed with bleeding into the brain's cavities and already have a drain tube in place, you may be able to join.

Boston, Massachusetts

Hear when a new Intraventricular Hemorrhage of Prematurity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.